Qube Research & Technologies (QRT)’s Taysha Gene Therapies TSHA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TSHA Stock Details TSHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Buy	+259,605	New	+$1.54M	﹤0.01%	2177
2024 Q4	–	Sell	-352,684	Closed	-$709K	–	3831
2024 Q3	$709K	Sell	352,684 -279,816	-44%	-$614K	﹤0.01%	2155
2024 Q2	$1.42M	Sell	632,500 -439,570	-41%	-$1.28M	﹤0.01%	1757
2024 Q1	$3.08M	Buy	1,072,070 +953,549	+805%	+$1.99M	﹤0.01%	1505
2023 Q4	$210K	Buy	+118,521	New	+$236K	﹤0.01%	2769
2022 Q4	–	Sell	-16,000	Closed	-$31K	–	3005
2022 Q3	$31K	Sell	16,000 -1,836	-10%	-$6.67K	﹤0.01%	2233
2022 Q2	$66K	Buy	+17,836	New	+$70.8K	﹤0.01%	2065

Other funds holding TSHA

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TSHA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 259,605 shares worth $1.77M. The stake represents ﹤0.01% of the portfolio and ranks #2177 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in TSHA as recently as Q3 2024.

Qube Research & Technologies (QRT) first reported a position in TSHA in Q2 2022 and has held it in 7 quarters since. The position peaked at $3.08M in Q1 2024. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

Qube Research & Technologies (QRT) held 259,605 shares of Taysha Gene Therapies worth $1.77M as of Q2 2026.
Taysha Gene Therapies was a new Qube Research & Technologies (QRT) position in Q2 2026.
Taysha Gene Therapies made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2177 holding.
Qube Research & Technologies (QRT) first reported a position in Taysha Gene Therapies in Q2 2022 and has held it in 7 quarters since.
Qube Research & Technologies (QRT)'s Taysha Gene Therapies position peaked at $3.08M in Q1 2024.
208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.